Regulus Therapeutics Inc. sell StockNews.com
Start price
18.05.25
/
50%
€7.00
Target price
18.05.26
-
Performance (%)
0.00%
End price
19.05.26
-
Summary
This prediction is currently being closed. The SELL prediction by StockNews_com is currently unchanged from the start price. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regulus Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1.842% | 1.387% | 8.651% |
| iShares Nasdaq 100 | 4.659% | -1.797% | 27.823% |
| iShares Nikkei 225® | 3.963% | -5.216% | 51.810% |
| iShares S&P 500 | 3.700% | 1.576% | 24.086% |
Comments by StockNews_com for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for RGLS provided by MarketBeat
In the thread Trading Regulus Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.25
10.05.25
10.05.25
-
10.05.26
10.05.26
-2.76%
11.05.26
11.05.26
